{"id":"W1989523897","doi":"10.1111/j.1365-2036.2012.05189.x","title":"Review article: non‐malignant haematological complications of anti‐tumour necrosis factor alpha therapy","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Cilag; UCB Pharma; Biogen; Sanofi; AstraZeneca; Genentech; Amgen","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Adverse effect; Internal medicine; Tumor necrosis factor alpha; Immunology; Gastroenterology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001434928,0.0006102746,0.001479956,0.00005239669,0.000127618,0.00001037921,0.000542435,0.0003925608,0.000359137],"category_scores_gemma":[2.509892e-7,0.0004545386,0.0006358401,0.0001984325,0.0002407703,0.000008405734,0.0001828935,0.0002421472,0.00006924152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003979737,"about_ca_system_score_gemma":0.0002199382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000176464,"about_ca_topic_score_gemma":0.000002391346,"domain_scores_codex":[0.9975945,0.0003534734,0.0008139989,0.0005667679,0.0001460419,0.0005252148],"domain_scores_gemma":[0.9985897,0.00005431804,0.0005787718,0.0005388534,0.00008639866,0.0001519461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008884703,0.006546976,0.001398627,0.01070943,0.05280864,0.00002147817,0.00008802356,7.104844e-7,0.04630116,0.00002968046,0.005937105,0.8760693],"study_design_scores_gemma":[0.0009935942,0.0003577059,0.0001287476,0.001217544,0.02053688,0.00008946094,0.000004267506,0.000001031962,0.02123545,0.00000975742,0.9549637,0.0004618632],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002616713,0.9944484,0.00001254881,0.000393554,0.0003560744,0.001707838,0.0003689688,0.00001940235,0.00007646636],"genre_scores_gemma":[0.004874466,0.9840998,0.0001811674,0.009164825,0.0001188098,0.000380908,0.001054029,0.00007612888,0.00004986414],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9490266,"threshold_uncertainty_score":0.9997906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0958549959762631,"score_gpt":0.3878390665469855,"score_spread":0.2919840705707224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}